Florida Cancer Specialists & Research Institute Supports American Cancer Society Guidelines for Colonoscopies
November 22, 2022 08:00 ET
|
Florida Cancer Specialists & Research Institute
Ft. Myers, Fla., Nov. 22, 2022 (GLOBE NEWSWIRE) -- Florida Cancer Specialists & Research Institute, LLC (FCS) takes exception to a recent study published in the New England Journal of...
Florida Cancer Specialists & Research Institute Supports American Cancer Society Guidelines for Colonoscopies
November 22, 2022 08:00 ET
|
Florida Cancer Specialists & Research Institute
Ft. Myers, Fla., Nov. 22, 2022 (GLOBE NEWSWIRE) -- Florida Cancer Specialists & Research Institute, LLC (FCS) takes exception to a recent study published in the New England Journal of...
Mainz Biomed to Participate in Deutsche Eigenkapitalforum and Cantor Fitzgerald’s Medical & Aesthetic Dermatology, Ophthalmology & MedTech Conference
November 22, 2022 08:00 ET
|
Mainz BioMed NV
BERKELEY, Calif. and MAINZ, Germany, Nov. 22, 2022 (GLOBE NEWSWIRE) -- Mainz Biomed NV (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the...
Mainz Biomed Announces U.S. Extension of ColoFuture Study to Evaluate Integration of Novel mRNA Biomarkers into ColoAlert
November 15, 2022 08:00 ET
|
Mainz BioMed NV
eAArly DETECT expected to complete enrollment in Q1 2023 with results in 1H 2023Enhances ColoFuture’s demographic profile and expedites data read-out timelinePotential to identify advanced adenomas, a...
Cancer Monoclonal Antibodies Market Is A $108.47 Billion Opportunity; Successful Cancer Therapeutic Strategies
November 10, 2022 07:02 ET
|
STRATEGIC MARKET RESEARCH LLP
New York, USA, Nov. 10, 2022 (GLOBE NEWSWIRE) -- The Worldwide Cancer Monoclonal Antibodies Market size in 2021 was USD 51.88 billion and will be worth USD 108.47 billion with an 8.54% CAGR. A...
Mainz Biomed Provides Third Quarter 2022 Update
November 02, 2022 08:00 ET
|
Mainz BioMed NV
BERKELEY, Calif. and MAINZ, Germany, Nov. 02, 2022 (GLOBE NEWSWIRE) -- Mainz Biomed NV (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the...
With 4.3% CAGR, Colorectal Cancer Screening Market Size worth USD 22.88 Billion in 2029
October 31, 2022 05:59 ET
|
Fortune Business Insights
Pune, India, Oct. 31, 2022 (GLOBE NEWSWIRE) -- The colorectal cancer screening market size was valued at USD 14.32 billion in 2021. It is anticipated to touch USD 22.88 billion by 2029 at a CAGR of...
Colorectal Cancer Clinical Trials Pipeline Analysis Featuring 125+ Key Companies by DelveInsight
October 26, 2022 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, Oct. 26, 2022 (GLOBE NEWSWIRE) -- Colorectal Cancer Clinical Trials Pipeline Analysis Featuring 125+ Key Companies by DelveInsight Colorectal Cancer Pipeline constitutes 125+ key...
Artificial Intelligence in Oncology Market Report 2022: Lower Rates of Diagnostic & Treatment Errors Brought By AI Boosts Adoption
October 07, 2022 08:43 ET
|
Research and Markets
Dublin, Oct. 07, 2022 (GLOBE NEWSWIRE) -- The "Artificial Intelligence in Oncology Market: Distribution by Type of Cancer, Type of End-Users and Key Geographical Regions: Industry Trends and Global...
Biomerica’s Aware® Breast Self Exam and EZ Detect™ Colon Disease Test Now Available on Amazon and Fulfilled by Amazon
September 29, 2022 08:19 ET
|
Biomerica, Inc.
Aware® is a simple at-home device to increase sensitivity in breast self-exams. About 80% of breast cancer is detected by women themselves who notice changes in their breast.EZ Detect™ is a simple...